Millennium Sub-Fund Updates Milestone Pharma Stake

TL;DR

**Millennium's sub-fund updated its Milestone Pharma stake, showing continued interest.**

AI Summary

Integrated Core Strategies (US) LLC, a subsidiary of Millennium Management LLC, filed an amended Schedule 13G/A on January 29, 2024, indicating their ownership of Milestone Pharmaceuticals Inc. common shares as of December 31, 2023. This filing, an amendment to a previous disclosure, updates their position in the pharmaceutical company. This matters to investors because it provides transparency into significant institutional holdings, potentially signaling confidence or a change in investment strategy by a major fund like Millennium Management.

Why It Matters

This filing shows that a major institutional investor, Integrated Core Strategies (US) LLC, continues to hold a position in Milestone Pharmaceuticals, offering a glimpse into their investment strategy.

Risk Assessment

Risk Level: low — This is a routine amendment to a Schedule 13G filing, providing transparency without indicating any immediate negative or positive event for the company.

Analyst Insight

Investors should note that a significant institutional investor, Integrated Core Strategies (US) LLC (part of Millennium Management), maintains a position in Milestone Pharmaceuticals. While this filing doesn't reveal the size of the stake, it confirms continued interest, which could be a positive signal for long-term holders or those considering the stock.

Key Players & Entities

• Integrated Core Strategies (US) LLC (company) — reporting person and a subsidiary of Millennium Management LLC
• Milestone Pharmaceuticals Inc. (company) — the issuer of the securities being reported
• Millennium Management LLC (company) — parent company of the reporting person
• Israel A. Englander (person) — listed as a group member, likely associated with Millennium Management LLC
• Delaware (company) — place of organization for Integrated Core Strategies (US) LLC

FAQ

Filing Documents

• MIST_SC13GA2.htm (SC 13G/A) — 92KB
• 0001319244-24-000017.txt ( ) — 94KB

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); CUSIP No. 59935V107 SCHEDULE 13G Page 7 of 11 (g) o A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: See response to Item 9 on each cover page. (b) Percent of Class: See response to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote See response to Item 5 on each cover page. CUSIP No. 59935V107 SCHEDULE 13G Page 8 of 11 (ii) Shared power to vote or to direct the vote See response to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of See response to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group See Exhibit I.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 59935V107 SCHEDULE 13G Page 9 of 11 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 26, 2024, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. CUSIP No. 59935V107 SCHEDULE 13G Page 10 of 11 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: January 26, 2024 INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander CUSIP No. 59935V107 SCHEDULE 13G Page 11 of 11 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Shares, no par value, of Milestone Pharmaceuticals Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as ame

View Full Filing

View this SC 13G/A filing on SEC EDGAR